CAR-T Cell Therapy Market Size to Surpass USD 14.42 Billion by 2030, exhibiting a CAGR of 18.5%
25 sept. 2023 06h33 HE
|
Fortune Business Insights
Pune, India, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Global CAR-T Cell Therapy Market Size was valued at USD 2.72 billion in 2022 and is projected to grow from USD 14.42 billion by 2030 exhibiting a CAGR...
Global CAR T-cell Therapy Market is Anticipated to Reach US$ 21.8 Billion by 2031, Expanding at a 30.6% CAGR: TMR Report
20 sept. 2023 09h27 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Sept. 20, 2023 (GLOBE NEWSWIRE) -- The CAR T-cell therapy market was estimated to have acquired US$ 1.1 billion in 2020. It is anticipated to register a 30.6%...
FDA Grants Fast Track designation to IVS-3001, a CAR-T Cell Therapy in the Treatment of Renal Cell Carcinoma
31 juil. 2023 06h00 HE
|
Invectys, Inc.
Houston, TX, USA, July 31, 2023 (GLOBE NEWSWIRE) -- Invectys, Inc., a clinical-stage immuno-oncology company focused on developing novel therapies for advanced cancers, is pleased to announce the...
Chimeric Antigen Receptor (CAR)-T Cell Therapy Market to Exhibit an Incredible Growth of USD 5.35 Billion by 2030, Size, Share, Trends, Key Drivers, Demand and Opportunity Analysis
14 avr. 2023 05h34 HE
|
Data Bridge Market Research
NEW YORK, April 14, 2023 (GLOBE NEWSWIRE) -- Data Bridge Market Research completed a qualitative study titled "Chimeric Antigen Receptor (CAR)-T Cell Therapy Market" with 100+ market data tables,...
Cell BioEngines Enters into an Exclusive Worldwide Agreement to Develop and Commercialize Potent Immune Cell States to Cure Cancer
25 janv. 2023 21h15 HE
|
Cell BioEngines, Inc.
BOSTON and NEW YORK, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Cell BioEngines Inc. (the “Company”), a cell and gene therapy company focused on developing an allogenic cell-based product for solid tumors,...
Comprehensive Analysis of 250+ Key Companies Developing 250+ Novel CAR-T Therapies: DelveInsight
20 avr. 2021 20h50 HE
|
DelveInsight Business Research LLP
Los Angeles, USA, April 20, 2021 (GLOBE NEWSWIRE) -- Comprehensive Analysis of 250+ Key Companies Developing 250+ Novel CAR-T Therapies: DelveInsight More than 50% of trials investigating...
CARsgen Therapeutics and CrownBio complete CAR-T study for gastric cancer
13 sept. 2018 08h00 HE
|
Crown Bioscience
SAN DIEGO, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation,...